XRAYDENTSPLY SIRONA Inc. shows solid thematic potential and balanced fundamentals, yet technical indicators suggest a cautious stance in the short term. Suitable for investors seeking moderate growth with exposure to dental healthcare innovations.
The company is well positioned in the dental and healthcare consumables market with a diverse product portfolio and steady innovation, aligned with growing healthcare demand.
Financials reflect challenges with negative net income and significant debt load, although free cash flow is positive and the company maintains liquidity. Valuation metrics are unattractive due to losses.
Technical indicators suggest a mixed picture with some short-term selling pressure but longer-term support evident. Current momentum and moving averages show cautious signals for near-term price action.
| Factor | Score |
|---|---|
| Market Focus & Segments | 80 |
| Innovation Pipeline | 75 |
| ESG & Sustainability | 60 |
| Geographic & Market Presence | 65 |
| Regulatory Environment | 70 |
| Factor | Score |
|---|---|
| Valuation | 30 |
| Profitability | 25 |
| Growth | 40 |
| Balance Sheet Health | 50 |
| Cash Flow | 65 |
| Factor | Score |
|---|---|
| Trend Analysis | 60 |
| Momentum | 55 |
| Volume Confirmation | 60 |
| Support & Resistance | 65 |
Attractive Dividend Yield
The company has a dividend yield around 4%, with recent dividends consistently paid, indicating a stable shareholder return policy.
Strong Free Cash Flow Generation
Positive free cash flow in recent quarters, including $281M annual FCF in 2024Q4, supports ongoing operations and dividend sustainability.
Negative Earnings and Profitability
Trailing twelve months and recent year net income are significantly negative (e.g., -$904M TTM), with negative EPS and net margins, signaling ongoing profitability challenges.
Negative P/E and High Volatility in Valuation Ratios
The company shows negative P/E ratios historically and volatile quarterly P/E swings (e.g., large negative to very high positive values), suggesting earnings uncertainty.
June 2025
27
Ex-Dividend Date
July 2025
11
Next Dividend Date
August 2025
7
Next Earnings Date
H: $0.55
A: $0.50
L: $0.46
H: 952.00M
A: 929.67M
L: 889.00M
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers intermittent urinary catheters under the LoFric brand and irrigation systems under the Navina brand. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
18.14 USD
The 39 analysts offering 1 year price forecasts for XRAY have a max estimate of 25.00 and a min estimate of 14.00.